SCHEDULE 13D/A: Saba Capital Reduces Stake in Nuveen Core Plus Impact Fund to 4.93%
Beneficial Ownership Change
Saba Capital Management, L.P. and its affiliates have reduced their beneficial ownership in Nuveen Core Plus Impact Fund to 4.93% through a series of open market sales.
Summary
- Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") filed Amendment No. 9 to Schedule 13D.
- The filing reports a change in beneficial ownership of Common Shares ($0.01 par value) of Nuveen Core Plus Impact Fund.
- As of March 5, 2025, the Reporting Persons beneficially own an aggregate of 1,418,628 common shares.
- This represents 4.93% of the 28,755,000 common shares outstanding as of June 30, 2024, as disclosed in the company's N-CSRS filed September 5, 2024.
- The total approximate amount paid by the Reporting Persons to acquire the reported common shares was $16,462,292.
- Funds for the acquisition of shares were derived from subscription proceeds from investors, capital appreciation, and margin account borrowings.
- Between February 25, 2025, and March 5, 2025, Saba Capital executed several open market sales of Nuveen Core Plus Impact Fund shares, with prices ranging from $10.91 to $11.10 per share.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of a change in beneficial ownership and related transactions. While the reduction in stake by a significant investor could be interpreted negatively by some, the document itself does not provide context or commentary from the issuer to indicate a positive or negative outlook for the company's performance. Therefore, it is assessed as neutral.
Negatives
- The Reporting Persons, a significant investor group, reduced their beneficial ownership in Nuveen Core Plus Impact Fund from a previously higher stake to 4.93% through open market sales.
- The sale of shares by a notable investment manager like Saba Capital could be perceived by the market as a negative signal regarding the fund's future prospects or the Reporting Persons' investment strategy.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the future performance or strategy of Nuveen Core Plus Impact Fund.
Industry Context
This filing represents a change in a significant holding by Saba Capital Management, a firm known for its activist investment strategies, in a closed-end fund. Such changes in ownership by large institutional investors can influence market perception and potentially signal a shift in investment thesis or a reduction in activist engagement.
Legal Proceedings
- The Reporting Persons have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
- The Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws, or finding any violation with respect to such laws, during the last five years.
Stakeholder Impact
- Shareholders: The reduction in beneficial ownership by Saba Capital Management, a prominent investment firm, may lead to speculation among existing shareholders regarding the firm's long-term view of Nuveen Core Plus Impact Fund, potentially influencing trading behavior.
Key Dates
| Date | Description |
|---|---|
| 2015-11-16 | Date of power of attorney for Michael D'Angelo, incorporated by reference. |
| 2015-12-28 | Date Schedule 13G was filed by the Reporting Persons, incorporated by reference. |
| 2024-06-30 | Date as of which 28,755,000 common shares outstanding were disclosed by the company. |
| 2024-09-05 | Date Nuveen Core Plus Impact Fund's N-CSRS was filed, disclosing shares outstanding. |
| 2025-02-25 | Start date of reported open market sales by Saba Capital. |
| 2025-03-03 | Trade date for sale of 75,735 shares at $11.10. |
| 2025-03-04 | Trade date for sale of 70,810 shares at $10.97. |
| 2025-03-05 | Date of the event which required the filing of this Schedule 13D/A, and last trade date for reported sales. |
| 2025-03-07 | Date of signatures on the Schedule 13D/A filing. |
Keywords
Nuveen Core Plus Impact Fund, Saba Capital Management, Schedule 13D, Beneficial Ownership, Investment Fund, Common Shares, Shareholding, SEC Filing, Closed-End Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.